Johnson & Johnson (JNJ)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 03-2017 | 12-2016 | 09-2016 | 06-2016 | 03-2016 | |
| Cash Flows From Operating Activities | |||||
| Net Income | 4,422,000 | 16,540,000 | 12,726,000 | 8,454,000 | 4,457,000 |
| Depreciation Amortization | 912,000 | 3,754,000 | 2,699,000 | 1,791,000 | 891,000 |
| Income taxes - deferred | -27,000 | -341,000 | 215,000 | 115,000 | 393,000 |
| Accounts receivable | -109,000 | -1,076,000 | -746,000 | -1,102,000 | -390,000 |
| Other Working Capital | -2,660,000 | -1,784,000 | -4,141,000 | -4,088,000 | -3,839,000 |
| Other Operating Activity | 375,000 | 1,674,000 | 1,361,000 | 1,583,000 | 677,000 |
| Operating Cash Flow | $2,913,000 | $18,767,000 | $12,114,000 | $6,753,000 | $2,189,000 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | -529,000 | -1,959,000 | -1,260,000 | -711,000 | -614,000 |
| Net Acquisitions | -4,852,000 | -4,509,000 | -4,050,000 | -730,000 | -5,000 |
| Purchase Of Investment | -4,550,000 | -33,950,000 | -27,677,000 | -17,511,000 | -10,062,000 |
| Sale Of Investment | 8,994,000 | 35,780,000 | 30,437,000 | 18,775,000 | 9,145,000 |
| Other Investing Activity | 1,000 | -123,000 | -37,000 | -38,000 | -1,000 |
| Investing Cash Flow | $-936,000 | $-4,761,000 | $-2,587,000 | $-215,000 | $-1,537,000 |
| Cash Flows From Financing Activities | |||||
| Change In Short Term Borrowing | 719,000 | 111,000 | 149,000 | 118,000 | 95,000 |
| Debt Issued | 4,464,000 | 12,004,000 | 11,951,000 | 11,951,000 | 7,435,000 |
| Debt Repayment | -2,000 | -2,223,000 | -953,000 | -936,000 | -14,000 |
| Common Stock Issued | 402,000 | 1,189,000 | 1,112,000 | 929,000 | 510,000 |
| Common Stock Repurchased | -3,342,000 | -8,979,000 | -6,954,000 | -4,751,000 | -2,389,000 |
| Dividend Paid | -2,171,000 | -8,621,000 | -6,451,000 | -4,266,000 | -2,069,000 |
| Other Financing Activity | -220,000 | -2,032,000 | -3,941,000 | -4,687,000 | -4,172,000 |
| Financing Cash Flow | $-150,000 | $-8,551,000 | $-5,087,000 | $-1,642,000 | $-604,000 |
| Exchange Rate Effect | 110,000 | -215,000 | 33,000 | 12,000 | 81,000 |
| Beginning Cash Position | 18,972,000 | 13,732,000 | 13,732,000 | 13,732,000 | 13,732,000 |
| End Cash Position | 20,909,000 | 18,972,000 | 18,205,000 | 18,640,000 | 13,861,000 |
| Net Cash Flow | $1,937,000 | $5,240,000 | $4,473,000 | $4,908,000 | $129,000 |
| Free Cash Flow | |||||
| Operating Cash Flow | 2,913,000 | 18,767,000 | 12,114,000 | 6,753,000 | 2,189,000 |
| Capital Expenditure | -560,000 | -3,226,000 | -2,133,000 | -1,396,000 | -639,000 |
| Free Cash Flow | 2,353,000 | 15,541,000 | 9,981,000 | 5,357,000 | 1,550,000 |